Global Respiratory Distress Syndrome Market Growth (Status and Outlook) 2022-2028
As the global economy mends, the 2021 growth of Respiratory Distress Syndrome will have significant change from previous year. According to our latest study, the global Respiratory Distress Syndrome market size is USD million in 2022 from USD 369.5 million in 2021, with a change of % between 2021 and 2022. The global Respiratory Distress Syndrome market size will reach USD 544.9 million in 2028, growing at a CAGR of 5.7% over the analysis period.
The United States Respiratory Distress Syndrome market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Respiratory Distress Syndrome market, reaching US$ million by the year 2028. As for the Europe Respiratory Distress Syndrome landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Respiratory Distress Syndrome players cover Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, and AbbVie, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Respiratory Distress Syndrome market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Poractant Alfa
Beractant
Calfactant
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Very Preterm Infants
Moderate to Late Preterm Infants
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Chiesi Farmaceutici
CR-Double Crane
ONY Biotech
AbbVie
Yuhan Corporation
JW Pharmaceuticals
Noargen
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Respiratory Distress Syndrome Market Size 2017-2028
2.1.2 Respiratory Distress Syndrome Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Respiratory Distress Syndrome Segment by Type
2.2.1 Poractant Alfa
2.2.2 Beractant
2.2.3 Calfactant
2.2.4 Others
2.3 Respiratory Distress Syndrome Market Size by Type
2.3.1 Respiratory Distress Syndrome Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Respiratory Distress Syndrome Market Size Market Share by Type (2017-2022)
2.4 Respiratory Distress Syndrome Segment by Application
2.4.1 Very Preterm Infants
2.4.2 Moderate to Late Preterm Infants
2.4.3 Others
2.5 Respiratory Distress Syndrome Market Size by Application
2.5.1 Respiratory Distress Syndrome Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Respiratory Distress Syndrome Market Size Market Share by Application (2017-2022)
3 Respiratory Distress Syndrome Market Size by Player
3.1 Respiratory Distress Syndrome Market Size Market Share by Players
3.1.1 Global Respiratory Distress Syndrome Revenue by Players (2020-2022)
3.1.2 Global Respiratory Distress Syndrome Revenue Market Share by Players (2020-2022)
3.2 Global Respiratory Distress Syndrome Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Respiratory Distress Syndrome by Regions
4.1 Respiratory Distress Syndrome Market Size by Regions (2017-2022)
4.2 Americas Respiratory Distress Syndrome Market Size Growth (2017-2022)
4.3 APAC Respiratory Distress Syndrome Market Size Growth (2017-2022)
4.4 Europe Respiratory Distress Syndrome Market Size Growth (2017-2022)
4.5 Middle East & Africa Respiratory Distress Syndrome Market Size Growth (2017-2022)
5 Americas
5.1 Americas Respiratory Distress Syndrome Market Size by Country (2017-2022)
5.2 Americas Respiratory Distress Syndrome Market Size by Type (2017-2022)
5.3 Americas Respiratory Distress Syndrome Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Respiratory Distress Syndrome Market Size by Region (2017-2022)
6.2 APAC Respiratory Distress Syndrome Market Size by Type (2017-2022)
6.3 APAC Respiratory Distress Syndrome Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Respiratory Distress Syndrome by Country (2017-2022)
7.2 Europe Respiratory Distress Syndrome Market Size by Type (2017-2022)
7.3 Europe Respiratory Distress Syndrome Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Respiratory Distress Syndrome by Region (2017-2022)
8.2 Middle East & Africa Respiratory Distress Syndrome Market Size by Type (2017-2022)
8.3 Middle East & Africa Respiratory Distress Syndrome Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Respiratory Distress Syndrome Market Forecast
10.1 Global Respiratory Distress Syndrome Forecast by Regions (2023-2028)
10.1.1 Global Respiratory Distress Syndrome Forecast by Regions (2023-2028)
10.1.2 Americas Respiratory Distress Syndrome Forecast
10.1.3 APAC Respiratory Distress Syndrome Forecast
10.1.4 Europe Respiratory Distress Syndrome Forecast
10.1.5 Middle East & Africa Respiratory Distress Syndrome Forecast
10.2 Americas Respiratory Distress Syndrome Forecast by Country (2023-2028)
10.2.1 United States Respiratory Distress Syndrome Market Forecast
10.2.2 Canada Respiratory Distress Syndrome Market Forecast
10.2.3 Mexico Respiratory Distress Syndrome Market Forecast
10.2.4 Brazil Respiratory Distress Syndrome Market Forecast
10.3 APAC Respiratory Distress Syndrome Forecast by Region (2023-2028)
10.3.1 China Respiratory Distress Syndrome Market Forecast
10.3.2 Japan Respiratory Distress Syndrome Market Forecast
10.3.3 Korea Respiratory Distress Syndrome Market Forecast
10.3.4 Southeast Asia Respiratory Distress Syndrome Market Forecast
10.3.5 India Respiratory Distress Syndrome Market Forecast
10.3.6 Australia Respiratory Distress Syndrome Market Forecast
10.4 Europe Respiratory Distress Syndrome Forecast by Country (2023-2028)
10.4.1 Germany Respiratory Distress Syndrome Market Forecast
10.4.2 France Respiratory Distress Syndrome Market Forecast
10.4.3 UK Respiratory Distress Syndrome Market Forecast
10.4.4 Italy Respiratory Distress Syndrome Market Forecast
10.4.5 Russia Respiratory Distress Syndrome Market Forecast
10.5 Middle East & Africa Respiratory Distress Syndrome Forecast by Region (2023-2028)
10.5.1 Egypt Respiratory Distress Syndrome Market Forecast
10.5.2 South Africa Respiratory Distress Syndrome Market Forecast
10.5.3 Israel Respiratory Distress Syndrome Market Forecast
10.5.4 Turkey Respiratory Distress Syndrome Market Forecast
10.5.5 GCC Countries Respiratory Distress Syndrome Market Forecast
10.6 Global Respiratory Distress Syndrome Forecast by Type (2023-2028)
10.7 Global Respiratory Distress Syndrome Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Chiesi Farmaceutici
11.1.1 Chiesi Farmaceutici Company Information
11.1.2 Chiesi Farmaceutici Respiratory Distress Syndrome Product Offered
11.1.3 Chiesi Farmaceutici Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Chiesi Farmaceutici Main Business Overview
11.1.5 Chiesi Farmaceutici Latest Developments
11.2 CR-Double Crane
11.2.1 CR-Double Crane Company Information
11.2.2 CR-Double Crane Respiratory Distress Syndrome Product Offered
11.2.3 CR-Double Crane Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 CR-Double Crane Main Business Overview
11.2.5 CR-Double Crane Latest Developments
11.3 ONY Biotech
11.3.1 ONY Biotech Company Information
11.3.2 ONY Biotech Respiratory Distress Syndrome Product Offered
11.3.3 ONY Biotech Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 ONY Biotech Main Business Overview
11.3.5 ONY Biotech Latest Developments
11.4 AbbVie
11.4.1 AbbVie Company Information
11.4.2 AbbVie Respiratory Distress Syndrome Product Offered
11.4.3 AbbVie Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 AbbVie Main Business Overview
11.4.5 AbbVie Latest Developments
11.5 Yuhan Corporation
11.5.1 Yuhan Corporation Company Information
11.5.2 Yuhan Corporation Respiratory Distress Syndrome Product Offered
11.5.3 Yuhan Corporation Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Yuhan Corporation Main Business Overview
11.5.5 Yuhan Corporation Latest Developments
11.6 JW Pharmaceuticals
11.6.1 JW Pharmaceuticals Company Information
11.6.2 JW Pharmaceuticals Respiratory Distress Syndrome Product Offered
11.6.3 JW Pharmaceuticals Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 JW Pharmaceuticals Main Business Overview
11.6.5 JW Pharmaceuticals Latest Developments
11.7 Noargen
11.7.1 Noargen Company Information
11.7.2 Noargen Respiratory Distress Syndrome Product Offered
11.7.3 Noargen Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Noargen Main Business Overview
11.7.5 Noargen Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Respiratory Distress Syndrome Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Poractant Alfa
Table 3. Major Players of Beractant
Table 4. Major Players of Calfactant
Table 5. Major Players of Others
Table 6. Respiratory Distress Syndrome Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Respiratory Distress Syndrome Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Respiratory Distress Syndrome Market Size Market Share by Type (2017-2022)
Table 9. Respiratory Distress Syndrome Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Respiratory Distress Syndrome Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Respiratory Distress Syndrome Market Size Market Share by Application (2017-2022)
Table 12. Global Respiratory Distress Syndrome Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Respiratory Distress Syndrome Revenue Market Share by Player (2020-2022)
Table 14. Respiratory Distress Syndrome Key Players Head office and Products Offered
Table 15. Respiratory Distress Syndrome Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Respiratory Distress Syndrome Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Respiratory Distress Syndrome Market Size Market Share by Regions (2017-2022)
Table 20. Americas Respiratory Distress Syndrome Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Respiratory Distress Syndrome Market Size Market Share by Country (2017-2022)
Table 22. Americas Respiratory Distress Syndrome Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Respiratory Distress Syndrome Market Size Market Share by Type (2017-2022)
Table 24. Americas Respiratory Distress Syndrome Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Respiratory Distress Syndrome Market Size Market Share by Application (2017-2022)
Table 26. APAC Respiratory Distress Syndrome Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Respiratory Distress Syndrome Market Size Market Share by Region (2017-2022)
Table 28. APAC Respiratory Distress Syndrome Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Respiratory Distress Syndrome Market Size Market Share by Type (2017-2022)
Table 30. APAC Respiratory Distress Syndrome Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Respiratory Distress Syndrome Market Size Market Share by Application (2017-2022)
Table 32. Europe Respiratory Distress Syndrome Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Respiratory Distress Syndrome Market Size Market Share by Country (2017-2022)
Table 34. Europe Respiratory Distress Syndrome Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Respiratory Distress Syndrome Market Size Market Share by Type (2017-2022)
Table 36. Europe Respiratory Distress Syndrome Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Respiratory Distress Syndrome Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Respiratory Distress Syndrome Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Respiratory Distress Syndrome Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Respiratory Distress Syndrome Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Respiratory Distress Syndrome Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Respiratory Distress Syndrome Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Respiratory Distress Syndrome Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Respiratory Distress Syndrome
Table 45. Key Market Challenges & Risks of Respiratory Distress Syndrome
Table 46. Key Industry Trends of Respiratory Distress Syndrome
Table 47. Global Respiratory Distress Syndrome Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Respiratory Distress Syndrome Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Respiratory Distress Syndrome Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Respiratory Distress Syndrome Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Respiratory Distress Syndrome Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Respiratory Distress Syndrome Market Size Market Share Forecast by Application (2023-2028)
Table 53. Chiesi Farmaceutici Details, Company Type, Respiratory Distress Syndrome Area Served and Its Competitors
Table 54. Chiesi Farmaceutici Respiratory Distress Syndrome Product Offered
Table 55. Chiesi Farmaceutici Respiratory Distress Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Chiesi Farmaceutici Main Business
Table 57. Chiesi Farmaceutici Latest Developments
Table 58. CR-Double Crane Details, Company Type, Respiratory Distress Syndrome Area Served and Its Competitors
Table 59. CR-Double Crane Respiratory Distress Syndrome Product Offered
Table 60. CR-Double Crane Main Business
Table 61. CR-Double Crane Respiratory Distress Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. CR-Double Crane Latest Developments
Table 63. ONY Biotech Details, Company Type, Respiratory Distress Syndrome Area Served and Its Competitors
Table 64. ONY Biotech Respiratory Distress Syndrome Product Offered
Table 65. ONY Biotech Main Business
Table 66. ONY Biotech Respiratory Distress Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. ONY Biotech Latest Developments
Table 68. AbbVie Details, Company Type, Respiratory Distress Syndrome Area Served and Its Competitors
Table 69. AbbVie Respiratory Distress Syndrome Product Offered
Table 70. AbbVie Main Business
Table 71. AbbVie Respiratory Distress Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. AbbVie Latest Developments
Table 73. Yuhan Corporation Details, Company Type, Respiratory Distress Syndrome Area Served and Its Competitors
Table 74. Yuhan Corporation Respiratory Distress Syndrome Product Offered
Table 75. Yuhan Corporation Main Business
Table 76. Yuhan Corporation Respiratory Distress Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Yuhan Corporation Latest Developments
Table 78. JW Pharmaceuticals Details, Company Type, Respiratory Distress Syndrome Area Served and Its Competitors
Table 79. JW Pharmaceuticals Respiratory Distress Syndrome Product Offered
Table 80. JW Pharmaceuticals Main Business
Table 81. JW Pharmaceuticals Respiratory Distress Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. JW Pharmaceuticals Latest Developments
Table 83. Noargen Details, Company Type, Respiratory Distress Syndrome Area Served and Its Competitors
Table 84. Noargen Respiratory Distress Syndrome Product Offered
Table 85. Noargen Main Business
Table 86. Noargen Respiratory Distress Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. Noargen Latest Developments
List of Figures
Figure 1. Respiratory Distress Syndrome Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Respiratory Distress Syndrome Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Respiratory Distress Syndrome Market Size Market Share by Type in 2021
Figure 7. Respiratory Distress Syndrome in Very Preterm Infants
Figure 8. Global Respiratory Distress Syndrome Market: Very Preterm Infants (2017-2022) & ($ Millions)
Figure 9. Respiratory Distress Syndrome in Moderate to Late Preterm Infants
Figure 10. Global Respiratory Distress Syndrome Market: Moderate to Late Preterm Infants (2017-2022) & ($ Millions)
Figure 11. Respiratory Distress Syndrome in Others
Figure 12. Global Respiratory Distress Syndrome Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Respiratory Distress Syndrome Market Size Market Share by Application in 2021
Figure 14. Global Respiratory Distress Syndrome Revenue Market Share by Player in 2021
Figure 15. Global Respiratory Distress Syndrome Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Respiratory Distress Syndrome Market Size 2017-2022 ($ Millions)
Figure 17. APAC Respiratory Distress Syndrome Market Size 2017-2022 ($ Millions)
Figure 18. Europe Respiratory Distress Syndrome Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Respiratory Distress Syndrome Market Size 2017-2022 ($ Millions)
Figure 20. Americas Respiratory Distress Syndrome Value Market Share by Country in 2021
Figure 21. Americas Respiratory Distress Syndrome Consumption Market Share by Type in 2021
Figure 22. Americas Respiratory Distress Syndrome Market Size Market Share by Application in 2021
Figure 23. United States Respiratory Distress Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Respiratory Distress Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Respiratory Distress Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Respiratory Distress Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Respiratory Distress Syndrome Market Size Market Share by Region in 2021
Figure 28. APAC Respiratory Distress Syndrome Market Size Market Share by Application in 2021
Figure 29. China Respiratory Distress Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Respiratory Distress Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Respiratory Distress Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Respiratory Distress Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Respiratory Distress Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Respiratory Distress Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Respiratory Distress Syndrome Market Size Market Share by Country in 2021
Figure 36. Europe Respiratory Distress Syndrome Market Size Market Share by Type in 2021
Figure 37. Europe Respiratory Distress Syndrome Market Size Market Share by Application in 2021
Figure 38. Germany Respiratory Distress Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Respiratory Distress Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Respiratory Distress Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Respiratory Distress Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Respiratory Distress Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Respiratory Distress Syndrome Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Respiratory Distress Syndrome Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Respiratory Distress Syndrome Market Size Market Share by Application in 2021
Figure 46. Egypt Respiratory Distress Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Respiratory Distress Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Respiratory Distress Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Respiratory Distress Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Respiratory Distress Syndrome Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Respiratory Distress Syndrome Market Size 2023-2028 ($ Millions)
Figure 52. APAC Respiratory Distress Syndrome Market Size 2023-2028 ($ Millions)
Figure 53. Europe Respiratory Distress Syndrome Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Respiratory Distress Syndrome Market Size 2023-2028 ($ Millions)
Figure 55. United States Respiratory Distress Syndrome Market Size 2023-2028 ($ Millions)
Figure 56. Canada Respiratory Distress Syndrome Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Respiratory Distress Syndrome Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Respiratory Distress Syndrome Market Size 2023-2028 ($ Millions)
Figure 59. China Respiratory Distress Syndrome Market Size 2023-2028 ($ Millions)
Figure 60. Japan Respiratory Distress Syndrome Market Size 2023-2028 ($ Millions)
Figure 61. Korea Respiratory Distress Syndrome Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Respiratory Distress Syndrome Market Size 2023-2028 ($ Millions)
Figure 63. India Respiratory Distress Syndrome Market Size 2023-2028 ($ Millions)
Figure 64. Australia Respiratory Distress Syndrome Market Size 2023-2028 ($ Millions)
Figure 65. Germany Respiratory Distress Syndrome Market Size 2023-2028 ($ Millions)
Figure 66. France Respiratory Distress Syndrome Market Size 2023-2028 ($ Millions)
Figure 67. UK Respiratory Distress Syndrome Market Size 2023-2028 ($ Millions)
Figure 68. Italy Respiratory Distress Syndrome Market Size 2023-2028 ($ Millions)
Figure 69. Russia Respiratory Distress Syndrome Market Size 2023-2028 ($ Millions)
Figure 70. Spain Respiratory Distress Syndrome Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Respiratory Distress Syndrome Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Respiratory Distress Syndrome Market Size 2023-2028 ($ Millions)
Figure 73. Israel Respiratory Distress Syndrome Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Respiratory Distress Syndrome Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Respiratory Distress Syndrome Market Size 2023-2028 ($ Millions)
